Cheelcare Closes $3.02M Upsized Placement, Investors Pay 130% Premium to Market Price
CHCRF is trading near its 52-week low of $0.655 (0.0% above the low).
Summary
Cheelcare Inc. successfully closed an upsized non-brokered private placement, raising $3.02 million. This significantly exceeds the initial $1.5 million target announced on June 11th, reflecting strong investor demand. The units were priced at $1.50, representing a substantial 130% premium over the current OTC stock price of $0.6551. This capital infusion will fund product development and commercialization activities. Notably, company directors and officers participated, investing $220,500, demonstrating strong insider conviction.
At the time of this announcement, CHCRF was trading at $0.66 on OTC in the Life Sciences sector. The 52-week trading range was $0.66 to $0.66. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: TMX Newsfile.